Search results
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 5 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 3 days agoAstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via Yahoo News· 5 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...
Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit
Daily Express· 5 days agoResults from a trial of daily pill lorlatinib were described as "unprecedented".
Pfizer drug extends life for people with rare form of lung cancer
AFP via Yahoo News· 5 days agoA Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...
Trial reveals benefits of 'stepped' palliative care for patients with advanced lung cancer
Medical Xpress· 2 days agoA new study led by investigators from Mass General Cancer Center reveals the effectiveness of more...
Does Palliative Care via Telehealth Work in Advanced Cancer?
Medscape· 2 days agoEarly palliative care can be delivered successfully and efficiently using telehealth in patients...
Late-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib...
Valley City Times Record· 1 day agoJohnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as a first-line treatment in patients with advanced ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
...I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer - Puma Biotechnology (NASDAQ:PBYI)
Benzinga· 1 day agoPuma Biotechnology, Inc. PBYI, a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor ...